Literature DB >> 22871501

Vitamin D for your patients with chronic hepatitis C?

Adeeb H Rahman1, Andrea D Branch.   

Abstract

Vitamin D is increasingly becoming recognized as an important physiological regulator with pleiotropic functions outside of its classical role in skeletal homeostasis. A growing body of clinical evidence highlights the prevalence and risks of vitamin D deficiency in patients suffering from chronic hepatitis C infection, and vitamin D supplementation has been proposed as an adjunct to current standards of care. This review considers the experimental evidence for the anti-inflammatory, antifibrotic and antiviral effects of vitamin D, and discusses the therapeutic potential of vitamin D supplementation to protect against liver disease progression and improve responses to treatment.
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871501     DOI: 10.1016/j.jhep.2012.07.026

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study.

Authors:  Andrea D Branch; Burc Barin; Adeeb Rahman; Peter Stock; Thomas D Schiano
Journal:  Liver Transpl       Date:  2013-12-12       Impact factor: 5.799

2.  Severe Vitamin D Deficiency Is Not Associated with Liver Damage in Morbidly Obese Patients.

Authors:  Rodolphe Anty; Audrey Hastier; Clémence M Canivet; Stéphanie Patouraux; Anne-Sophie Schneck; Patricia Ferrari-Panaia; Imed Ben-Amor; Marie Christine Saint-Paul; Jean Gugenheim; Philippe Gual; Antonio Iannelli; Albert Tran
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

Review 3.  Complementary and alternative medications in hepatitis C infection.

Authors:  Dina L Halegoua-De Marzio; Jonathan M Fenkel
Journal:  World J Hepatol       Date:  2014-01-27

Review 4.  Vitamin D, bone, and HIV infection.

Authors:  Michael Yin
Journal:  Top Antivir Med       Date:  2012-12

5.  GC Gene Polymorphism and Unbound Serum Retinol-Binding Protein 4 Are Related to the Risk of Insulin Resistance in Patients With Chronic Hepatitis C: A Prospective Cross-Sectional Study.

Authors:  Beatriz Mateos-Muñoz; Elena García-Martín; María J Torrejón; María J Devesa-Medina; Gara Esguevillas; María C Cárdenas; Cristina Fernández; Miguel Carballo; José A Agúndez; José M Ladero
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 6.  Vitamin D deficiency in patients with liver cirrhosis.

Authors:  Christos Konstantakis; Paraskevi Tselekouni; Maria Kalafateli; Christos Triantos
Journal:  Ann Gastroenterol       Date:  2016-04-25

7.  25-Vitamin D levels in chronic hepatitis C infection: association with cirrhosis and sustained virologic response.

Authors:  David Backstedt; Mark Pedersen; Myunghan Choi; Anil Seetharam
Journal:  Ann Gastroenterol       Date:  2017-01-05

8.  Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.

Authors:  Kessarin Thanapirom; Sirinporn Suksawatamnuay; Wattana Sukeepaisarnjaroen; Pisit Tangkijvanich; Sombat Treeprasertsuk; Panarat Thaimai; Rujipat Wasitthankasem; Yong Poovorawan; Piyawat Komolmit
Journal:  BMC Gastroenterol       Date:  2017-04-17       Impact factor: 3.067

Review 9.  Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?

Authors:  Ning Ding; Christopher Liddle; Ronald M Evans; Michael Downes
Journal:  Expert Rev Clin Pharmacol       Date:  2013-11       Impact factor: 5.045

Review 10.  Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.

Authors:  Sajad Fakhri; Zeinab Nouri; Seyed Zachariah Moradi; Esra Küpeli Akkol; Sana Piri; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.